The Million Lives Fund has launched a $100m venture capital fund that will invest in companies using technology to expand healthcare access and education, and improve healthcare quality and outcomes globally.
The Million Lives Fund will invest in commercial-stage companies developing and deploying technologies capable of improving and extending lives, including medical education innovations, remote patient monitoring solutions, tech-enabled care models, predictive analytics tools and clinical decision support solutions.
The inaugural fund is established by the Laerdal family and its operating companies, primarily Laerdal Medical and Laerdal Global Health.
Led by said Jeff Trost, managing partner, the Million Lives Fund has been actively building its portfolio, already backing four companies that align with its core values:
- Aloe Care Health, a provider of an advanced voice-activated medical alert and communication system for older adults and caregivers.
- Avive Solutions, developer of a next-generation emergency response platform aimed at increasing survival rates from sudden cardiac arrest (SCA).
- MobileODT, an AI-powered mobile device capable of providing equitable and standardized access to cervical cancer screening.
- RapidSOS, an emergency response data exchange providing life-saving information to 911 and emergency response systems.
The Million Lives Fund will invest in 15 to 20 companies with its first fund. It will lead or syndicate with other investors, putting anywhere from $1 million to $10 million into each company over the life of the investment.
By partnering with global health organizations, the broader investment community, governments and other stakeholders, the fund seeks to efficiently invest in companies that touch as broad and diverse of a population as possible, regardless of demographics or geography.